BIOMARIN PHARMA earnings per share and revenue

BM8 earnings per share for the last quarter are 0.58 CHF whereas the estimation was 0.49 CHF which accounts for 19.84% surprise. Company revenue for the same period amounts to 678.42 M CHF despite the estimated figure of 646.91 M CHF. Estimated earnings per share for the next quarter are 0.62 CHF, and revenue is expected to reach 660.02 M CHF. Also watch annual changes over time to get a bigger picture of BM8 earnings per share and revenue dynamics.